Lipocine Inc. (NASDAQ: LPCN) Stock Information | RedChip

Lipocine Inc. (NASDAQ: LPCN)


$4.6500
+0.0600 ( +3.80% ) 3.2K

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

Market Data


Open


$4.6500

Previous close


$4.5900

Volume


3.2K

Market cap


$24.60M

Day range


$4.6350 - $5.0470

52 week range


$3.2000 - $11.7900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 61 Jan 13, 2025
4 Insider transactions 1 Jan 02, 2025
4/a Other 1 Jan 02, 2025
8-k 8K-related 15 Dec 17, 2024
8-k 8K-related 60 Dec 13, 2024
8-k 8K-related 15 Nov 18, 2024
8-k 8K-related 14 Nov 07, 2024
10-q Quarterly Reports 69 Nov 07, 2024
8-k 8K-related 16 Nov 05, 2024
8-k 8K-related 16 Oct 31, 2024

Latest News